Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.59% | -588.21% | 124.39% | -115.38% | 1,633.96% |
| Total Depreciation and Amortization | 108.02% | 14.87% | 1.73% | 108.17% | 18.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.35% | 9,557.05% | -98.41% | 109.00% | -2,030.04% |
| Change in Net Operating Assets | 118.46% | -15.09% | 87.54% | -248.48% | 234.46% |
| Cash from Operations | 66.31% | 46.38% | 146.77% | 77.73% | -1,117.27% |
| Capital Expenditure | 83.94% | 51.92% | -180.25% | 36.23% | -29.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.14% | -- | -- | 97.91% | -- |
| Divestitures | -- | -- | 81.52% | -26.43% | -- |
| Other Investing Activities | 326.19% | -121.75% | 31.05% | -67.87% | 131.96% |
| Cash from Investing | 130.68% | -277.45% | 35.39% | 661.68% | -91.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 33.33% | -94.23% | -3.70% | -16.92% | 364.29% |
| Repurchase of Common Stock | 2.85% | -622.68% | 67.59% | 3.02% | -60.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -88.89% | 97.26% | -- | -- | -- |
| Cash from Financing | 2.68% | -390.34% | 50.69% | 2.52% | -57.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 100.00% | -507.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 144.38% | -252.79% | 237.82% | 122.03% | -251.45% |